Canopy Growth Operating Income Over Time
| WEED Stock | CAD 1.57 0.05 3.09% |
With this module, investors can use any or all of fundamental ratio historical patterns as a complementary method for asset selection as well as a tool for deciding entry and exit points. Many technical investors use fundamentals to limit their universe of possible portfolio assets.
Check out Canopy Growth Performance and Canopy Growth Correlation. Canopy |
Cross Equities Operating Income Analysis
Compare Canopy Growth Corp and related stocks such as Cipher Pharmaceuticals, OrganiGram Holdings, and TerrAscend Corp Operating Income Over Time
Select Fundamental| 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| CPH | (6 M) | (2.4 M) | 2.4 M | 17.1 M | (4.8 M) | (68 K) | (31.8 M) | 25.2 M | 5.3 M | 11.7 M | 12.2 M | 11.8 M | 12 M | 11.5 M | 7.8 M | 9 M | 9.5 M |
| OGI | (140.2 K) | (140.2 K) | (375.2 K) | (66.8 K) | (1.8 M) | 1.2 M | (11.1 M) | 36.4 M | 5.5 M | (145.5 M) | (91.8 M) | (43.2 M) | (242.7 M) | (35.7 M) | (88.3 M) | (79.5 M) | (75.5 M) |
| TSND | (866.9 K) | (866.9 K) | (866.9 K) | (866.9 K) | (866.9 K) | (866.9 K) | (866.9 K) | (6.7 M) | (28.2 M) | (65 M) | (49.3 M) | 50.9 M | (41.5 M) | (19.9 M) | (17.1 M) | (15.4 M) | (16.2 M) |
| ACB | (1.2 K) | (330.8 K) | (402.9 K) | (306.5 K) | (4.4 M) | (4.6 M) | (11.2 M) | (95.8 M) | (318.3 M) | (465.8 M) | (282.8 M) | (231.4 M) | (254.3 M) | (46.5 M) | 4.9 M | 4.5 M | 4.7 M |
| EDT | (3 M) | (6.8 M) | (8.6 M) | (11.4 M) | (10.2 M) | (9.6 M) | (10.2 M) | (3.9 M) | (2.3 M) | (4.8 M) | (8.9 M) | (6.7 M) | (8.4 M) | (11.4 M) | (12 M) | (13.8 M) | (14.5 M) |
| HITI | 1.6 M | 1.6 M | 1.6 M | 1.6 M | 1.6 M | 1.6 M | 958.8 K | (3.7 M) | (19.6 M) | (677 K) | (18.7 M) | (20.1 M) | (41.4 M) | 15.3 M | 15.3 M | 13.8 M | 14.5 M |
| NGEN | (11.8 K) | (11.8 K) | (11.8 K) | (11.8 K) | (11.8 K) | (11.8 K) | (11.8 K) | (11.8 K) | (1.4 M) | (9.9 M) | (11.2 M) | (12.9 M) | (22.8 M) | (17.8 M) | (24.9 M) | (22.4 M) | (21.3 M) |
| FRX | (1.6 M) | (3.4 M) | (3.6 M) | (1.9 M) | (2.9 M) | (1.9 M) | (2.9 M) | (7 M) | (10.4 M) | (13 M) | (17.9 M) | (17.2 M) | (22.6 M) | (12.8 M) | 2.6 M | 2.3 M | 2.4 M |
| XLY | 17.4 K | 115.5 K | 138.1 K | 81.3 K | 46.4 K | 40.8 K | (359.4 K) | (16.6 M) | (50.6 M) | (61 M) | (54 M) | (42 M) | (46.8 M) | (19 M) | 14.7 M | 13.2 M | 13.9 M |
Canopy Growth Corp and related stocks such as Cipher Pharmaceuticals, OrganiGram Holdings, and TerrAscend Corp Operating Income description
Operating Income is the amount of profit realized from Canopy Growth Corp operations after accounting for operating expenses such as cost of goods sold (COGS), wages and depreciation. Operating income takes the gross income and subtracts other operating expenses and then removes depreciation. Operating Income of Canopy Growth Corp is typically a synonym for earnings before interest and taxes (EBIT) and is also commonly referred to as operating profit or recurring profit. Earnings before interest and taxes (EBIT), representing the amount of profit a company generates from its operations.My Equities
My Current Equities and Potential Positions
| Canopy Growth Corp | WEED |
Specialization | Health Care, Pharmaceuticals, Biotechnology & Life Sciences |
| Business Address | 1 Hershey Drive, |
| Exchange | Toronto Exchange |
CAD 1.57
Check out Canopy Growth Performance and Canopy Growth Correlation. You can also try the Portfolio Optimization module to compute new portfolio that will generate highest expected return given your specified tolerance for risk.
Canopy Growth technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.